Published in Gastroenterology Week, September 25th, 2006
Study 1: Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells.
"Human studies have shown that chronic inorganic arsenic (iAs) exposure is associated with a high prevalence and incidence of type 2 diabetes. However, the mechanism(s) underlying this effect are not well understood, and practically, there is no information available on the effects of arsenic on pancreatic beta-cells functions," researchers in Mexico report.
"Thus," wrote A. Diaz-Villasenor and colleagues, National Autonomous...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.